These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35793124)

  • 1. Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study.
    Krishnamurti L; Arnold SD; Haight A; Abraham A; Guilcher GM; John T; Bakshi N; Shenoy S; Syrjala K; Martin PL; Chaudhury S; Eames G; Olowoselu OF; Hsieh M; De La Fuente J; Kasow KA; Stenger E; Mertens A; El-Rassi F; Lane P; Shaw BE; Meacham L; Archer D
    JMIR Res Protoc; 2022 Jul; 11(7):e36780. PubMed ID: 35793124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation.
    George SA; Veludhandi A; Xiang Y; Liu K; Stenger E; Arnold SD; Mehta A; Schirmer DA; Spencer JB; Guilcher GMT; Bhatia M; Abraham A; Gomez-Lobo V; Krishnamurti L; Meacham LR
    Transplant Cell Ther; 2024 Sep; 30(9):912.e1-912.e13. PubMed ID: 38972510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease.
    Bhatia M; Kolva E; Cimini L; Jin Z; Satwani P; Savone M; George D; Garvin J; Paz ML; Briamonte C; Cruz-Arrieta E; Sands S
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):666-72. PubMed ID: 25559691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic cell transplantation for sickle cell disease: updates and future directions.
    Krishnamurti L
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):181-189. PubMed ID: 34889368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.
    Walters MC; De Castro LM; Sullivan KM; Krishnamurti L; Kamani N; Bredeson C; Neuberg D; Hassell KL; Farnia S; Campbell A; Petersdorf E
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):207-211. PubMed ID: 26500093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review/Meta-Analysis on Efficacy of Allogeneic Hematopoietic Cell Transplantation in Sickle Cell Disease: An International Effort on Behalf of the Pediatric Diseases Working Party of European Society for Blood and Marrow Transplantation and the Sickle Cell Transplantation International Consortium.
    Iqbal M; Reljic T; Corbacioglu S; de la Fuente J; Gluckman E; Kumar A; Yassine F; Ayala E; El-Jawahri A; Murthy H; Almohareb F; Hashmi SK; Cappelli B; Alahmari A; Scigliuolo GM; Kassim A; Aljurf M; Kharfan-Dabaja MA
    Transplant Cell Ther; 2021 Feb; 27(2):167.e1-167.e12. PubMed ID: 33830027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal phenotyping and correlates of pain following hematopoietic cell transplant in children with sickle cell disease.
    Bakshi N; Astles R; Chou E; Hurreh A; Sil S; Sinha CB; Sanders KA; Peddineni M; Gillespie SE; Keesari R; Krishnamurti L
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30046. PubMed ID: 36322607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance.
    Stenger E; Xiang Y; Wetzel M; Gillespie S; Chellapandian D; Shah R; Arnold SD; Bhatia M; Chaudhury S; Eckrich MJ; Kanter J; Kasow KA; Krajewski J; Nickel RS; Ngwube AI; Olson TS; Rangarajan HG; Wobma H; Guilcher GMT; Horan JT; Krishnamurti L; Shenoy S; Abraham A
    Transplant Cell Ther; 2023 Jan; 29(1):47.e1-47.e10. PubMed ID: 36273784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018.
    Valcarcel B; Schonfeld SJ; Meyer CL; Brunson A; Cooley JJP; Abrahão R; Wun T; Auletta JJ; Gadalla SM; Engels E; Albert PS; Spellman SR; Rizzo JD; Shaw BE; Muffly L; Keegan THM; Morton LM
    Transplant Cell Ther; 2024 Feb; 30(2):239.e1-239.e11. PubMed ID: 37981238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
    Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
    Phelan R; Im A; Hunter RL; Inamoto Y; Lupo-Stanghellini MT; Rovo A; Badawy SM; Burns L; Eissa H; Murthy HS; Prasad P; Sharma A; Suelzer E; Agrawal V; Aljurf M; Baker K; Basak GW; Buchbinder D; DeFilipp Z; Grkovic LD; Dias A; Einsele H; Eisenberg ML; Epperla N; Farhadfar N; Flatau A; Gale RP; Greinix H; Hamilton BK; Hashmi S; Hematti P; Jamani K; Maharaj D; Murray J; Naik S; Nathan S; Pavletic S; Peric Z; Pulanic D; Ross R; Salonia A; Sanchez-Ortega I; Savani BN; Schechter T; Shah AJ; Smith SM; Snowden JA; Steinberg A; Tremblay D; Vij SC; Walker L; Wolff D; Yared JA; Schoemans H; Tichelli A
    Transplant Cell Ther; 2022 Jun; 28(6):335.e1-335.e17. PubMed ID: 34757220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Decision Support Tool for Allogeneic Hematopoietic Stem Cell Transplantation for Children With Sickle Cell Disease: Acceptability and Usability Study.
    Veludhandi A; Ross D; Sinha CB; McCracken C; Bakshi N; Krishnamurti L
    JMIR Form Res; 2021 Oct; 5(10):e30093. PubMed ID: 34709190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601.
    King AA; McKinstry RC; Wu J; Eapen M; Abel R; Varughese T; Kamani N; Shenoy S
    Biol Blood Marrow Transplant; 2019 May; 25(5):e174-e178. PubMed ID: 30639825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study.
    Arora M; Sun CL; Ness KK; Teh JB; Wu J; Francisco L; Armenian SH; Schad A; Namdar G; Bosworth A; Kuo L; Weisdorf DJ; Forman SJ; Bhatia S
    JAMA Oncol; 2016 Oct; 2(10):1277-1286. PubMed ID: 27254472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease.
    Krishnamurti L; Kharbanda S; Biernacki MA; Zhang W; Baker KS; Wagner JE; Wu CJ
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1270-8. PubMed ID: 18940682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic cell transplantation.
    Monagel DA; Guilcher GMT; Nettel-Aguirre A; Bendiak GN
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29927. PubMed ID: 35927947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Shenoy S; Gaziev J; Angelucci E; King A; Bhatia M; Smith A; Bresters D; Haight AE; Duncan CN; de la Fuente J; Dietz AC; Baker KS; Pulsipher MA; Walters MC
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1313-1321. PubMed ID: 29653206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.
    Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Auletta JJ; Badawy SM; Bhatt N; Bhatt VR; Cahn JY; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Gale RP; Hashem H; Hashmi S; Hematti P; Hong S; Hossain NM; Inamoto Y; Lekakis LJ; Modi D; Patel S; Sharma A; Solomon S; Couriel DR
    Transplant Cell Ther; 2022 Oct; 28(10):712.e1-712.e8. PubMed ID: 35863740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful.
    Shaw BE; Brazauskas R; Millard HR; Fonstad R; Flynn KE; Abernethy A; Vogel J; Petroske C; Mattila D; Drexler R; Lee SJ; Horowitz MM; Rizzo JD
    Cancer; 2017 Dec; 123(23):4687-4700. PubMed ID: 28817182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.